Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77d9bf55e6700374867763cc2c6acaff |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
filingDate |
2001-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_779d358eaf1c5d2dff6cb05f44d1c64c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19f5d1e67f2e0127c94cd9f71421687d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc28e41cad9bbae1c63c0666a0d6b03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe495ffed995a3157012eee645482f50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed90f8b3162d88fb0fb5f34c31fe628 |
publicationDate |
2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1309718-A2 |
titleOfInvention |
Neutrokine-alpha and neutrokine-alpha splice variant |
abstract |
The present invention relates to nucleic acid molecules encoding Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to antibodies or portions thereof that specifically bind Neutrokine-alpha and/or Neutrokine-alphaSV and diagnostic and therapeutic methods using these antibodies. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders using the compositions of the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071092-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9187548-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101181-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8062906-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7879328-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303951-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7605236-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173122-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8231873-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8212004-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211649-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168286-B2 |
priorityDate |
2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |